Milner group use combination of computational biology and machine learning to create comprehensive map of proteins involved in SARS-CoV-2 infection
Namshik Han’s group at the Milner Therapeutics Institute, have identified 200 approved drugs predicted to work against COVID-19 – of which only 40 are currently being tested in COVID-19 clinical trials. In a study published this week in Science Advances,...
Connect: Health Tech is launched
We are excited to announce that the University of Cambridge has launched the Connect: Health Tech microsite and online community platform, as part of the new University Enterprise Zone (UEZ) initiative. The delivery team behind Connect: Health Tech is the Milner...
Onco-Innovation collaborations awarded from pump prime call
Last month, the Onco-Innovation Programme — part of the CRUK Cambridge Centre and managed by our own Dr Rebecca Harris — launched a new rapid response data analysis pump prime call. This exciting new call was designed to seek collaborative project proposals from CRUK...
Milner collaboration targets RNA-modifying enzymes as promising anti-cancer strategy
Work at the Milner Therapeutics Institute by Director Tony Kouzarides and Kostas Tzelepis in collaboration with Storm Therapeutics has made a promising step towards developing a new drug for treating acute myeloid leukaemia. In a paper published today in Nature,...